NEWARK, DE /The drug-loaded pellets market is projected to expand from USD 1,650.0 million in 2026 to USD 3,450.0 million by 2036, registering a CAGR of 7.7% over the forecast period, according to Future Market Insights (FMI). This growth reflects a structural shift toward multiparticulate drug delivery systems that enable controlled and targeted release. Rising demand for improved...

The global Long-Acting Implant & Ocular Drug-Delivery Polymer Systems Market is undergoing a seismic shift in clinical standards, moving from episodic treatment models to continuous-elution architectures. According to the latest market analysis by Future Market Insights (FMI), the sector is projected to reach a valuation of USD 3.0 billion in 2026. Driven by a 6.8% CAGR,...

The global Pancreatic Stone Protein Testing Market stood at USD 2.30 Billion in 2026 and is forecast to reach USD 2.89 Billion by 2036, expanding at a CAGR of 2.3% over the decade. This growth reflects increasing clinical adoption of pancreatic stone protein (PSP) as an early biomarker for sepsis and infection-driven organ dysfunction, enabling detection...

The global Respiratory Inhaler Devices Market is projected to reach USD 68.1 billion by 2036, rising from USD 38.0 billion in 2026 at a CAGR of 6.0%. This steady expansion reflects the mounting global burden of chronic respiratory diseases and the accelerating transition toward advanced, low-carbon, and digitally enabled inhalation therapies. As healthcare systems adapt to rising...

NEWARK, DE | The self-administered biologics market was valued at USD 98.3 billion in 2025 and is estimated to reach USD 102.7 billion in 2026. Demand is projected to grow to USD 159.5 billion by 2036, reflecting a CAGR of 4.5% during the forecast period. This sustained expansion, with an absolute dollar growth of USD 56.8 billion over the decade, is anchored in the structural demand...

  The strategic importance of the United Kingdom's biologics sector extends beyond immediate healthcare applications, representing a cornerstone of economic development, scientific leadership, and industrial competitiveness in the post-pandemic era. The UK Biologics Market forecast indicates sustained expansion across multiple dimensions, including therapeutic area diversification,...

NEWARK, DE | The global Surgical Irrigation Market stood at USD 6,213.2 million in 2026 and is projected to reach USD 9,806.2 million by 2036, reflecting a steady CAGR of 4.7% over the forecast period. This growth underscores the essential role of sterile irrigation fluids, pumps, and accessories in supporting visualization, debris removal, and thermal control during orthopedic,...

The global oncology therapeutics industry is experiencing rapid advancement due to the increasing prevalence of cancer and the growing adoption of immunotherapy-based treatments. Tecentriq, an immunotherapy drug widely used in cancer treatment, has gained strong recognition for its effectiveness in managing various forms of cancer, including lung cancer and urothelial carcinoma. The increasing...

The Herceptin biosimilar market is expected to show consistent growth as regulatory confidence, reimbursement support, and oncology demand converge. The Herceptin Biosimilar Market forecast suggests that biosimilars will continue capturing larger shares of the oncology biologics segment through 2035. Factors such as increasing cancer prevalence, cost-containment policies, and expiry of patent...